Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2 Negative Breast Carcinoma|Recurrent Breast Carcinoma|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Stage III Breast Cancer
Interventions: BIOLOGICAL: CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine|OTHER: Laboratory Biomarker Analysis
Sponsor: University of Washington
Collaborators: United States Department of Defense|Breast Cancer Alliance